Agranulocytosis - 140 Studies Found
| Completed |
: G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer :
|
| Completed |
: A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy :
: 2007-11-07 : Other: EW02 |
| Terminated |
: Various G-CSF Regimens to Prevent Infection During Chemotherapy :
: 2007-09-25 : Drug: pegfilgrastim 6 mg s.c. 24-36 h post-chemotherapy |
| Terminated |
: Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy :
: 2007-07-12 : Biological: Maxy-G34 Maxy-G34 will be administered by subcutaneous injection during each of 6 TAC chemot |
| Completed |
: Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia :
: 2007-07-05 : Drug: AVI-014 versus Filgrastim 3 different dose arms of AVI-014 versus Filgrastim for up to 14 days dai |
| Completed |
: Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) :
: 2005-06-22 :
|
| Completed |
: Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy : Neutropenia : 2002-05-03 : Drug: pegfilgrastim Growth factor (GCSF) administered to promote neutrophil development post-chemotherap |
| Completed |
: Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer :
: 2002-02-14 :
|
| Completed |
: Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer :
: 1999-11-01 :
|
| Completed |
: A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer :
: Drug: FLAC chemotherapy with GM-CSF |